Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers
A variety of proton pump inhibitors (PPIs) have been developed in Korea since the introduction of omeprazole (the first PPI) in 1989. PPIs have served as the basic therapeutic approach for the management of gastric acid-related diseases for 30 years and remain among the most widely used drugs. Recen...
Saved in:
| Main Author: | Jong Kyu Park |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean College of Helicobacter and Upper Gastrointestinal Research
2023-09-01
|
| Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
| Subjects: | |
| Online Access: | http://www.helicojournal.org/upload/pdf/kjhugr-2023-0034.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endoscopic findings and outcomes of gastric mucosal changes relating to potassium‐competitive acid blocker and proton pump inhibitor therapy
by: Satoshi Shinozaki, et al.
Published: (2025-04-01) -
Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders
by: Mun Young Cho, et al.
Published: (2023-09-01) -
Role of Gastric Acid Suppression Therapy in Erosive Esophagitis: From H2 Receptor Antagonists, Proton Pump Inhibitors, to Potassium-Competitive Acid Blockers
by: Ryan Herardi, et al.
Published: (2025-07-01) -
Efficacy of Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors for Gastric Ulcers: Bayesian and Frequentist Network Meta-Analysis With Cross-Inference Through a Quality management System
by: In Mo Yoon, MD, PhD, et al.
Published: (2025-01-01) -
Role of Potassium-Competitive Acid Blockers in Helicobacter pylori Eradication
by: Jong Kyu Park
Published: (2017-03-01)